4//SEC Filing
REATA PHARMACEUTICALS INC 4
Accession 0001209191-17-040074
CIK 0001358762operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 3:01 PM ET
Size
8.0 KB
Accession
0001209191-17-040074
Insider Transaction Report
Form 4
Bass James Edward
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-14+6,000→ 6,000 totalExercise: $25.52Exp: 2027-06-14→ Class B common stock (6,000 underlying) - Award
Stock Option (right to buy)
2017-06-14$17.46/sh+1,052$18,368→ 1,052 totalExercise: $25.52Exp: 2027-06-14→ Class B common stock (1,052 underlying)
Footnotes (3)
- [F1]The options vest in 4 equal installments on September 14, 2017, December 14, 2017, March 14, 2018, and June 14, 2018, subject to continued service through each vesting date.
- [F2]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- [F3]This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $18,375.00.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001358762
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 3:01 PM ET
- Size
- 8.0 KB